Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1133 | 1133 | 1280 | 1414 | 1778 | 2232 |
Fund Return | 13.32% | 13.32% | 27.96% | 12.25% | 12.2% | 8.36% |
Place in category | 245 | 245 | 304 | 193 | 172 | 66 |
% in Category | 54 | 54 | 73 | 61 | 80 | 76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nomura Foreign Equity Index Fund MS | 745.05B | 15.83 | 21.22 | 14.09 | ||
Nomura India Equity | 478.49B | 9.94 | 18.85 | 13.43 | ||
Nomura Nomu Wrap Fund Neutral | 385.23B | 7.16 | 8.56 | 6.54 | ||
Nomura DC Foreign Equity Index Fund | 336.35B | 15.83 | 21.22 | 14.08 | ||
Nomura Wld Sector Ser Wld SC Equity | 284.8B | 40.50 | 40.92 | 28.52 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MUKAM eMAXIS Slim All World Equity | 3,159.59B | 19.62 | 19.70 | - | ||
Invesco Global Select Eq (UnH / MD) | 1,347.59B | 10.57 | 21.94 | 9.67 | ||
Pictet Global Income Equity Div 1M | 919.89B | 5.86 | 10.76 | 6.21 | ||
JP90C000KAH8 | 1,117.41B | 39.66 | 7.02 | - | ||
JP90C000JW79 | 796.82B | - | - | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Thermo Fisher Scientific | US8835561023 | 5.18 | 568.74 | -1.41% | |
Novo Nordisk A/S Class B | DK0060534915 | 4.21 | - | - | |
UnitedHealth | US91324P1021 | 4.18 | 483.70 | -1.09% | |
Boston Scientific | US1011371077 | 3.84 | 71.86 | -0.88% | |
Reckitt Benckiser | GB00B24CGK77 | 3.55 | 4,524.0 | +1.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review